Tranexamic Acid Shortage Update: What Patients Need to Know in 2026

If you've been taking tranexamic acid for heavy menstrual bleeding or a bleeding disorder, questions about availability may feel personal and urgent. Here's the most current information on the tranexamic acid shortage situation in 2026 — what happened, where things stand today, and what you should do to protect your access to this medication.

Current Shortage Status (2026)

As of 2026, tranexamic acid oral tablets are not on the FDA's official Drug Shortages database. Generic 650 mg tablets are manufactured by multiple companies including Amring Pharmaceuticals, Teva Pharmaceuticals, ANI Pharmaceuticals, and Advagen Pharma. This multi-manufacturer landscape is good news — it means no single factory shutdown can cause a nationwide outage.

However, this does not mean every pharmacy will have tranexamic acid ready and waiting. Localized stock gaps happen regularly, especially at smaller pharmacies or in areas where demand spikes seasonally. The injectable (IV) form of tranexamic acid — used in hospitals for surgical and trauma settings — can still face intermittent availability challenges at the institutional level.

The History of the Tranexamic Acid Shortage

To understand the current situation, it helps to know the history:

2009: The FDA approved Lysteda (tranexamic acid 650 mg tablets) — the first non-hormonal oral treatment for heavy menstrual bleeding in the United States. Ferring Pharmaceuticals was the manufacturer.

2020: Ferring Pharmaceuticals discontinued Lysteda. The FDA and ASHP listed tranexamic acid oral tablets as an official drug shortage. Patients and pharmacies scrambled for alternatives.

2021: The ASHP drug shortage bulletin was updated to note that Amring Pharmaceuticals and Teva both had tranexamic acid tablets available. The official shortage was resolved.

2025: The FDA issued enhanced safety communications for tranexamic acid injection, requiring stronger labeling about the risk of accidental neuraxial (intrathecal) injection. This affected injectable TXA protocols but not the oral tablet supply.

2026: Generic oral tranexamic acid is widely available through wholesale channels. Localized gaps remain possible.

Why Do Localized Shortages Still Happen?

Even without a national shortage, patients can encounter empty shelves for several reasons:

Pharmacy ordering patterns: Smaller pharmacies may only keep a week or two of inventory on hand.

Cyclical demand: Women with 28-day cycles tend to refill at similar intervals, creating predictable demand surges.

Wholesaler allocation limits: Even when manufacturers have product, distributors may allocate limited quantities to certain regions.

Brand name confusion: Some patients ask for "Lysteda" (which no longer exists), and pharmacies may incorrectly report the medication as unavailable.

What Should Patients Do Right Now?

Whether or not your pharmacy currently has tranexamic acid, here are proactive steps every patient should take:

Refill early, before your cycle: Ask for your prescription 7-10 days before you need it to allow time to find an alternative pharmacy if your first choice is out.

Always ask for "generic tranexamic acid": Clarify with your pharmacist that you want generic tranexamic acid 650 mg tablets, not the discontinued brand Lysteda.

Use medfinder if you're having trouble locating it — medfinder calls pharmacies in your area to find which ones can fill your prescription, then texts you the results.

Consider a 90-day supply: If your doctor can write a 90-day prescription and your insurance allows mail-order fills, this removes the monthly hunt entirely.

Discuss alternatives with your doctor: Know in advance what your backup plan is. Aminocaproic acid (Amicar) is the most direct alternative if TXA is truly unavailable.

How to Monitor the Shortage Status Yourself

You can check the official shortage status of any medication at these resources:

FDA Drug Shortages Database: accessdata.fda.gov/scripts/drugshortages — official FDA list of current shortages

ASHP Drug Shortages: ashp.org/drug-shortages — detailed shortage bulletins with manufacturer and resolution information

Drugs.com shortage notices: drugs.com/drug-shortages — consumer-friendly shortage updates

The Bottom Line

Tranexamic acid is not in a national shortage in 2026, but localized availability problems are real and can affect patients at the worst possible time. Planning ahead, knowing your alternatives, and using tools like medfinder to quickly identify which pharmacies near you have your medication are the best defenses against running out.